Last Price$254.01.2%
Market Cap$21.2B
LTM Research & Development Expenses (R&D)
$0.0
YoY Growth
-100.0%
3Y CAGR
N/A
5Y CAGR
N/A
Stock quality & Intrinsic value
6/10
144.4% undervalued
Laboratory Corporation of America Holdings Research & Development Expenses (R&D)
Annual
Quarterly
LTM
Crunching data... Almost there!
| Dec'04 | Dec'05 | Dec'06 | Dec'07 | Dec'08 | Dec'09 | Dec'10 | Dec'11 | Dec'12 | Dec'13 | Dec'14 | Dec'15 | Dec'16 | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Research & Development Expenses (R&D) | $0.0 | $0.0 | $0.0 | $0.0 | $0.0 | $0.0 | $0.0 | $0.0 | $0.0 | $0.0 | $0.0 | $0.0 | $0.0 | $0.0 | $0.0 | $0.0 | $0.0 | $0.0 | $0.0 | $2,000.0K |
Overvalued or undervalued?
Check the intrinsic value for LH
and see if it's the right time to invest.
Laboratory Corporation of America Holdings (LH) Research & Development Expenses (R&D) comparison analysis
General
LTM Research & Development Expenses (R&D)
Growth
Company name
YoY growth
3Y CAGR
5Y CAGR
Laboratory Corporation of America HoldingsLH
$0.0
(100.0%)
N/A
N/A
Median Peer Set
$288.7M
3.1%
0.3%
5.4%
Danaher CorporationDHR
$1,584.0M
5.4%
(3.1%)
4.9%
Thermo Fisher Scientific Inc.TMO
$1,390.0M
4.0%
(0.4%)
6.7%
Illumina, Inc.ILMN
$1,172.0M
(12.7%)
(0.4%)
12.6%
Agilent Technologies, Inc.A
$464.0M
(2.9%)
0.7%
2.7%
Natera, Inc.NTRA
$357.6M
9.8%
16.7%
48.7%
IDEXX Laboratories, Inc.IDXX
$219.8M
15.1%
10.9%
10.5%
Mettler-Toledo International Inc.MTD
$189.4M
2.2%
3.7%
5.6%
Waters CorporationWAT
$183.0M
4.6%
2.8%
5.1%
Quest Diagnostics IncorporatedDGX
$0.0
N/A
N/A
N/A
IQVIA Holdings Inc.IQV
$0.0
N/A
N/A
N/A
LH key stats
USD
Millions
Billions
Annual
Quarterly
Trailing
Key stats
Income statement
Balance sheet
Cash Flow Statement
Valuation
Ratios
Per share
Per employee
Dividends & Yields
| Dec'04 | Dec'05 | Dec'06 | Dec'07 | Dec'08 | Dec'09 | Dec'10 | Dec'11 | Dec'12 | Dec'13 | Dec'14 | Dec'15 | Dec'16 | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
% growth | 3,084.8 0.0% | 3,327.6 7.9% | 3,590.8 7.9% | 4,068.2 13.3% | 4,505.2 10.7% | 4,694.7 4.2% | 5,003.9 6.6% | 5,542.3 10.8% | 5,671.4 2.3% | 5,808.3 2.4% | 6,011.6 3.5% | 8,680.1 44.4% | 9,641.8 11.1% | 10,441.4 8.3% | 11,333.4 8.5% | 11,554.8 2.0% | 13,978.5 21.0% | 16,120.9 15.3% | 14,876.8 (7.7%) | 12,161.6 (18.3%) |
| Cost of Goods Sold (COGS) | 1,795.5 | 1,937.3 | 2,061.4 | 2,377.0 | 2,631.4 | 2,723.8 | 2,906.1 | 3,267.6 | 3,421.7 | 3,585.1 | 3,808.5 | 5,776.8 | 6,461.3 | 6,977.4 | 8,157.0 | 8,302.3 | 9,025.7 | 10,496.6 | 10,491.7 | 8,796.7 |
% margin | 1,289.3 41.8% | 1,390.3 41.8% | 1,529.4 42.6% | 1,691.2 41.6% | 1,873.8 41.6% | 1,970.9 42.0% | 2,097.8 41.9% | 2,274.7 41.0% | 2,249.7 39.7% | 2,223.2 38.3% | 2,203.1 36.6% | 2,903.3 33.4% | 3,180.5 33.0% | 3,464.0 33.2% | 3,176.4 28.0% | 3,252.5 28.1% | 4,952.8 35.4% | 5,624.3 34.9% | 4,385.1 29.5% | 3,364.9 27.7% |
| Operating Expenses | 691.8 | 755.3 | 831.3 | 863.6 | 1,030.9 | 1,021.5 | 1,107.0 | 1,245.4 | 1,200.9 | 1,210.5 | 1,274.9 | 1,786.5 | 1,809.7 | 2,028.9 | 1,802.6 | 1,867.7 | 2,004.7 | 2,321.7 | 2,255.9 | 2,639.3 |
| Research & Development Expenses (R&D) | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 2.0 |
| Selling, General & Administrative Expenses (SG&A) | 649.1 | 703.9 | 779.1 | 808.7 | 935.1 | 958.9 | 1,034.3 | 1,159.6 | 1,114.6 | 1,128.8 | 1,198.2 | 1,622.0 | 1,630.2 | 1,812.4 | 1,570.9 | 1,624.5 | 1,729.3 | 1,952.1 | 1,996.6 | 2,021.4 |
% margin | 598.4 19.4% | 618.1 18.6% | 697.1 19.4% | 777.0 19.1% | 842.9 18.7% | 935.9 19.9% | 978.8 19.6% | 948.4 17.1% | 1,023.5 18.0% | 990.9 17.1% | 910.4 15.1% | 1,002.9 11.6% | 1,312.4 13.6% | 1,364.2 13.1% | 1,325.7 11.7% | 1,330.2 11.5% | 2,445.4 17.5% | 3,259.5 20.2% | 1,773.9 11.9% | 725.6 6.0% |
| Interest Income | 0.0 | 0.0 | 0.0 | 0.0 | 2.5 | 1.6 | 1.1 | 1.3 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 8.8 | 10.3 | 10.2 | 8.9 | 0.0 |
| Interest Expense | 0.0 | 0.0 | 0.0 | 0.0 | 72.0 | 62.9 | 70.0 | 87.5 | 94.5 | 103.7 | 109.5 | 274.9 | 219.1 | 235.1 | 244.2 | 240.7 | 207.4 | 212.1 | 180.3 | 199.6 |
| Pre-tax Income | 615.3 | 640.7 | 720.9 | 802.3 | 772.4 | 884.6 | 915.6 | 866.1 | 944.2 | 915.6 | 826.7 | 732.1 | 1,105.5 | 1,134.9 | 1,268.3 | 1,104.9 | 2,219.1 | 3,126.6 | 1,582.6 | 568.9 |
% effective tax rate | 252.3 41.0% | 254.5 39.7% | 289.3 40.1% | 325.5 40.6% | 307.9 39.9% | 329.0 37.2% | 344.0 37.6% | 333.0 38.4% | 359.4 38.1% | 340.2 37.2% | 314.1 38.0% | 294.1 40.2% | 372.3 33.7% | (139.1) (12.3%) | 384.4 30.3% | 280.0 25.3% | 662.1 29.8% | 747.1 23.9% | 302.0 19.1% | 188.5 33.1% |
% margin | 363.0 11.8% | 386.2 11.6% | 431.6 12.0% | 476.8 11.7% | 464.5 10.3% | 543.3 11.6% | 558.2 11.2% | 519.7 9.4% | 583.1 10.3% | 573.8 9.9% | 511.2 8.5% | 436.9 5.0% | 732.1 7.6% | 1,268.2 12.1% | 883.7 7.8% | 823.8 7.1% | 1,556.1 11.1% | 2,377.3 14.7% | 1,279.1 8.6% | 418.0 3.4% |
| EPS | 2.60 | 2.89 | 3.48 | 4.08 | 4.60 | 4.98 | 5.45 | 5.31 | 6.24 | 6.70 | 6.03 | 4.42 | 7.14 | 12.39 | 8.71 | 8.41 | 15.99 | 24.58 | 14.04 | 4.80 |
| Diluted EPS | 2.45 | 2.71 | 3.24 | 3.93 | 4.60 | 4.98 | 5.29 | 5.11 | 5.99 | 6.25 | 5.91 | 4.34 | 7.02 | 12.21 | 8.61 | 8.36 | 15.88 | 24.38 | 13.96 | 4.77 |
% margin | 790.2 25.6% | 784.8 23.6% | 853.1 23.8% | 990.4 24.3% | 1,035.7 23.0% | 1,140.8 24.3% | 1,189.2 23.8% | 1,180.9 21.3% | 1,259.9 22.2% | 1,238.5 21.3% | 1,175.6 19.6% | 1,576.8 18.2% | 1,809.6 18.8% | 1,845.8 17.7% | 2,064.6 18.2% | 2,116.9 18.3% | 3,251.5 23.3% | 4,278.7 26.5% | 1,954.4 13.1% | 1,349.4 11.1% |
Discover more Stock Ideas
Undervalued stocks right now
Discover the top 20 best undervalued stocks to buy for Mar 2025, listed on the Nasdaq or NYSE.
3M Return 32.1%
S&P Outperformance 19.1%
Next 3M Predicted Return 20.3%
Undervalued growth stocks
Discover the top 20 best undervalued large-cap growth stocks to buy for Mar 2025, listed on the Nasdaq or NYSE.
3M Return 35.3%
S&P Outperformance 22.3%
Next 3M Predicted Return 26.8%
Undervalued dividend stocks
Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Mar 2025.
3M Return 28.4%
S&P Outperformance 15.4%
Next 3M Predicted Return 16.9%
FAQ
1) What is Laboratory Corporation of America Holdings's Research & Development Expenses (R&D)?
As of today, Laboratory Corporation of America Holdings's last 12-month Research & Development Expenses (R&D) is $0.0, based on the financial report for Dec 31, 2024 (Q4’2024).
2) What is Laboratory Corporation of America Holdings's Research & Development Expenses (R&D) growth rate?
Over the last year, Laboratory Corporation of America Holdings's Research & Development Expenses (R&D) growth was (100.0%). The average annual Research & Development Expenses (R&D) growth rates for Laboratory Corporation of America Holdings have been N/A over the past three years, N/A over the past five years.
3) Is Laboratory Corporation of America Holdings's Research & Development Expenses (R&D) growth rate Good?
Over the last year, Laboratory Corporation of America Holdings's Research & Development Expenses (R&D) growth was (100.0%), which is lower than industry growth of (0.3%). It indicates that Laboratory Corporation of America Holdings's Research & Development Expenses (R&D) growth is Good.